Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
10 Must-Read Posts In GU Oncology This Week
Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes, jointly presented by the Departments of Pediatrics and Surgery at Memorial Sloan Kettering Cancer Center (MSK), will take place on 19 October 2026, from […]
